PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.\', \'Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.\', \'Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.\', \'Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.\', \'Vita-Salute San Raffaele University, Milan, Italy.\', \'Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. Moiola.lucia@hsr.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00415-021-10663-x
?:doi
?:hasPublicationType
?:journal
  • Journal of neurology
is ?:pmid of
?:pmid
?:pmid
  • 34189719
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.626
?:rankingScore_hIndex
  • 118
is ?:relation_isRelatedTo_publication of
?:title
  • Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all